Price variation analysis of various drugs used for thromboembolic disorders currently available in Indian pharmaceutical market

Abstract

Background Major population in developing countries purchases medicine through out-of-pocket payment thus making them the largest family expenditure item after food. As a result, medicines are unaffordable for large sections of the global population and a major burden on government budgets. In developing country India, price of drugs play a major role in prescribing a drug for treatment. Methods An analytical study was done for comparing price variations among various drugs prescribed in thromboembolic disorders. Indian Drug Review (IDR) (January 2019) and CIMS (October December 2018) was referred to know the maximum and minimum price in INR of drugs in all available strength and dosage forms being manufactured by different companies in India and percentage price variation was calculated. Results Wide variation in the price of several brands of same anticoagulants, fibrinolytics, antiplatelets and their combinations were found in Indian pharmaceutical market. Highest percentage price variation was found for Aspirin 150 mg + Clopidogrel 75 mg Tablet (741.03%) combination. Percentage price variation is >100% for all the different combinations of aspirin + clopidogrel. In single drug, highest percentage price variation was found for Aspirin 100 mg Tablet (435.13%) followed by Aspirin 75 mg Tablet (403.78%), Clopidogrel 75 mg Tablet (275%), Aspirin 50 mg Tablet (221.96 %). In single drug, lowest percentage price variation was found for Eftifibatide 20mg/10 ml injection (1.15%) followed by Tirofiban 5mg/100 ml injection (2.63%), Warfarin 5 mg Tablet (3.23%). Conclusion Steps should be taken by the government towards reduction in price variation among the various brands so as to them affordable and aim to improve the health status of community. This will definitely reduce the economic burden on government. The purpose of “Health for all” can only be achieved by efforts from all stakeholders.

Authors and Affiliations

Neeta J. Kanani

Keywords

Related Articles

Phytochemical screening of Desmostachya bipinnata, Canthium dicoccum Sebestiania chaemelea

Plants contain various phytochemical constituents i.e. primary and secondary metabolites. Various secondary metabolites have proved their therapeutic activities due to their medicinal properties. So phytochemical screeni...

A study on prescribing pattern of drugs prescribed in patients of acute myocardial infarction admitted in ICCU at a tertiary care hospital

Background Studies on prescription pattern have important value in the health set up and eventually provides insight into the efficiency of drug use and results of such research studies can be helpful to set priorities...

Evaluation of anti-hyperlipidemic activity of clerodendrum serratum linn on high cholesterol diet induced hyperlipidemia in rats

The main objective of the study was to investigate about the antihyperlipidemic activity of the ethanolic extract from the aerial parts of Clerodendrum serratum Linn (EECS). Qualitative analysis of the extract revealed t...

A review on carbapenem resistance and the role of pharmacist in antibiotic stewardship programmes in India

Carbapenems are a group of β-lactam antimicrobial agents with an exceptionally broad spectrum of activity. They are used as a last resort against many multi drug resistant, gram negative bacteria, and in cases of infecti...

Study of analgesic and anti-inflammatory activity of different fractions from Kydia calycina Roxb

The present study was carried out to evaluate the analgesic and anti-inflammatory activity of various fractions of toluene, ethyl acetate, butan-2-one and n-butyl alcohol of Kydia calycina Roxb (Malvaceae). The fraction...

Download PDF file
  • EP ID EP648398
  • DOI -
  • Views 45
  • Downloads 0

How To Cite

Neeta J. Kanani (2019). Price variation analysis of various drugs used for thromboembolic disorders currently available in Indian pharmaceutical market. International Journal of Research in Pharmacology & Pharmacotherapeutics (IJRPP), 8(2), 294-301. https://europub.co.uk/articles/-A-648398